Grey Fox Wealth Advisors, LLC

Position in JNJ — Johnson & Johnson

CIK 1965362 ROCKLAND, DE

Position in JNJ

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$2,553,160

+$134,182 QoQ

Shares Held

10,053

+1.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

3.46%

of 13F equity value

Holder Rank

#2,137

of 4,664 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Grey Fox Wealth Advisors, LLC holds $4,922,184 across 4 Drug Manufacturers - General names. JNJ ranks #1 (51.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	10,053	$2,553,160
2	LLY	ELI LILLY & Co	1,189	$1,426,122
3	ABBV	AbbVie Inc.	2,427	$610,730
4	MRK	Merck & Co., Inc.	2,585	$332,172

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,553,160	10,053	+1.6%	Shares	Sole	2026-07-17
2026-03-31	$2,418,978	9,896	-2.2%	Shares	Sole	2026-04-21
2025-12-31	$2,094,334	10,120	-2.3%	Shares	Sole	2026-02-12
2025-09-30	$1,921,507	10,363	-0.9%	Shares	Sole	2025-10-29
2025-06-30	$1,596,695	10,453	-0.1%	Shares	Sole	2025-08-06
2025-03-31	$1,735,183	10,463	-0.9%	Shares	Sole	2025-05-02
2024-12-31	$1,527,621	10,563	-1.5%	Shares	Sole	2025-02-11
2024-09-30	$1,738,579	10,728	-4.3%	Shares	Sole	2024-10-22
2024-06-30	$1,638,015	11,207	+1.8%	Shares	Sole	2024-07-30
2024-03-31	$1,740,880	11,005	-1.9%	Shares	Sole	2024-04-11
2023-12-31	$1,758,779	11,221	-2.8%	Shares	Sole	2024-01-18
2023-09-30	$1,798,289	11,546	-8.1%	Shares	Sole	2023-10-24
2023-06-30	$2,080,420	12,569	-11.1%	Shares	Sole	2023-08-03
2023-03-31	$2,191,855	14,141	-0.5%	Shares	Sole	2023-05-09
2022-12-31	$2,509,843	14,208	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.